國立虎尾科技大學 |

Frontiers in cancer research = evolutionary foundations, revolutionary directions /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Frontiers in cancer research/ edited by Carlo C. Maley, Mel Greaves.
Reminder of title:	evolutionary foundations, revolutionary directions /
other author:	Maley, Carlo C.
Published:	New York, NY :Springer New York : : 2016.,
Description:	xiv, 258 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Cancer - Research. -
Online resource:	http://dx.doi.org/10.1007/978-1-4939-6460-4
ISBN:	9781493964604

Frontiers in cancer research = evolutionary foundations, revolutionary directions /
Frontiers in cancer researchevolutionary foundations, revolutionary directions /[electronic resource] :edited by Carlo C. Maley, Mel Greaves. - New York, NY :Springer New York :2016. - xiv, 258 p. :ill., digital ;24 cm.

1. The Evolutionary Foundations of Cancer Research -- 2. The Role of Theory in Cancer Research -- 3. Population Genetics of Neoplasms -- 4. Diversity in Neoplasms -- 5. How do Mutant Clones Expand in Normal Tissue? -- 6. Cancer Stem Cells in Tumor Evolution -- 7. Measuring Rather than Imagining Somatic Cell Selection and Clonal Evolution -- 8. The Darwinian Dynamics of Motility and Metastasis -- 9. Applying Evolutionary Principles to Cancer Therapy -- 10. Mismatches with Our Ancestral Environments and Cancer Risk -- 11. The Evolution of Cancer Suppression Mechanisms -- 12. Epilogue: How can we Thwart the Evolutionary Resilience of Cancer?.

This is the ideal book for anyone contemplating starting a career in, or shifting their career to, studying the dynamics that drive cancer progression and its response to therapy. Topics include the theory and population genetics of cancers, genetic diversity within tumors (intra-tumor heterogeneity), understanding how mutant clones expand in tissues, the role of cancer stem cells in the dynamics of tumors, the evolution of metastasis, and how to improve cancer therapy by addressing the evolution of cancers in response to our interventions. There are also chapters on the patterns of cancer susceptibility in humans due to a mismatch between our modern environment and the environment in which our ancestors evolved, as well as a chapter on the evolution of cancer suppression mechanisms that have evolved in different species, particularly the large long-lived animals like elephants and whales that are better at suppressing cancers than humans. This book serves as a primer on the evolutionary and ecological theory of cancer- the framework upon which all the details of cancer may be hung. It is ideal for oncologists and cancer researchers interested in evolutionary theory, and evolutionary biologists and ecologists interested in gaining insights into cancer development and prevention.

ISBN: 9781493964604

Standard No.: 10.1007/978-1-4939-6460-4doiSubjects--Topical Terms:

783845
Cancer
--Research.

LC Class. No.: RC267

Dewey Class. No.: 616.994

Frontiers in cancer research = evolutionary foundations, revolutionary directions /
LDR:02937nam a2200313 a 4500 001 867958
003 DE-He213
005 20161123165509.0
006 m d
007 cr nn 008maaau
008 170720s2016 nyu s 0 eng d
020 $a 9781493964604 $q (electronic bk.)
020 $a 9781493964581 $q (paper)
024 7 $a 10.1007/978-1-4939-6460-4 $2 doi
035 $a 978-1-4939-6460-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC267
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.994 $2 23
090 $a RC267 $b .F935 2016
245 0 0 $a Frontiers in cancer research $h [electronic resource] : $b evolutionary foundations, revolutionary directions / $c edited by Carlo C. Maley, Mel Greaves.
260 $a New York, NY : $b Springer New York : $b Imprint: Springer, $c 2016.
300 $a xiv, 258 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. The Evolutionary Foundations of Cancer Research -- 2. The Role of Theory in Cancer Research -- 3. Population Genetics of Neoplasms -- 4. Diversity in Neoplasms -- 5. How do Mutant Clones Expand in Normal Tissue? -- 6. Cancer Stem Cells in Tumor Evolution -- 7. Measuring Rather than Imagining Somatic Cell Selection and Clonal Evolution -- 8. The Darwinian Dynamics of Motility and Metastasis -- 9. Applying Evolutionary Principles to Cancer Therapy -- 10. Mismatches with Our Ancestral Environments and Cancer Risk -- 11. The Evolution of Cancer Suppression Mechanisms -- 12. Epilogue: How can we Thwart the Evolutionary Resilience of Cancer?.
520 $a This is the ideal book for anyone contemplating starting a career in, or shifting their career to, studying the dynamics that drive cancer progression and its response to therapy. Topics include the theory and population genetics of cancers, genetic diversity within tumors (intra-tumor heterogeneity), understanding how mutant clones expand in tissues, the role of cancer stem cells in the dynamics of tumors, the evolution of metastasis, and how to improve cancer therapy by addressing the evolution of cancers in response to our interventions. There are also chapters on the patterns of cancer susceptibility in humans due to a mismatch between our modern environment and the environment in which our ancestors evolved, as well as a chapter on the evolution of cancer suppression mechanisms that have evolved in different species, particularly the large long-lived animals like elephants and whales that are better at suppressing cancers than humans. This book serves as a primer on the evolutionary and ecological theory of cancer- the framework upon which all the details of cancer may be hung. It is ideal for oncologists and cancer researchers interested in evolutionary theory, and evolutionary biologists and ecologists interested in gaining insights into cancer development and prevention.
650 0 $a Cancer $x Research. $3 783845
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Pharmacology/Toxicology. $3 593882
700 1 $a Maley, Carlo C. $3 1115218
700 1 $a Greaves, Mel. $3 1115219
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-1-4939-6460-4
950 $a Biomedical and Life Sciences (Springer-11642)